The EPS projection of HCA Holdings, Inc. (NYSE:HCA) for quarter ended 2016-09-30 is $1.44. Last week, the EPS forecast was $1.44 against target of $1.44, a month earlier. Two months ago, this estimate was $1.44 versus forecast of $1.44 three months earlier, implying a deviation of 0%.
HCA Holdings, Inc. (NYSE:HCA) stated that 18 days ago, its stock price was positively revised 6 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 5, 5, and 5, correspondingly.
EPS estimate downgrade for HCA Holdings, Inc. (NYSE:HCA) in the preceding 30, 120, 60 and 90 days were 0, 5, 5, and 5, correspondingly.
HCA Holdings, Inc. (NYSE:HCA) EPS target for the quarter closed 1 was $1.44, based on 13 recommendations. As reported on 2016-05-03 the EPS was $1.71. The change was $0.22, implying a percentage deviation of 14.77%. The projections showed a standard deviation of 0.04.
Quarterly Sales Estimates
HCA Holdings, Inc. (NYSE:HCA) yearly sales prediction for the fiscal 2017 stands at $11353.4 and the median estimate is at $11358. Almost 5 analysts issued sales target.
Highest sales target is $11474 while the lowest target is $11222 showing standard deviation of 96.378%.
As many as 5 analysts have sales targets revised upside while 5 reduced sales estimates, implying a deviation of 0%.
Last month, 5 revised sales number projection on upside while 5 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast. HCA Holdings, Inc. (NYSE:HCA) announced that the deviation in forecast was 0.215%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...